PorA variable regions of Neisseria meningitidis - PubMed (original) (raw)
PorA variable regions of Neisseria meningitidis
Joanne E Russell et al. Emerg Infect Dis. 2004 Apr.
Abstract
Subtypes, defined by variation in the outer membrane protein PorA, are an integral part of the characterization scheme for Neisseria meningitidis. Identification of these variants remains important as the PorA protein is a major immunogenic component of several meningococcal vaccines under development, and characteristics of PorA are used to provide detailed epidemiologic information. Historically, serosubtypes have been defined by reactivity with a set of monoclonal antibodies. However, nucleotide sequence analyses of porA genes have established that the panel of serosubtyping monoclonal antibodies is not exhaustive, and many porA variants cannot be detected. In addition, the nomenclature system used to define subtypes is inadequate. We examined all available nucleotide sequences of the porA VR1 and VR2 regions to identify and define subtype families. A revised nomenclature scheme, compatible with the previous serologic nomenclature scheme, was devised. A Web-accessible database describing this nomenclature and its relationship to previous schemes was established (available from: http://neisseria.org/nm/typing/pora).
Figures
Figure 1
Alignment of the amino acid and corresponding nucleotide sequence of each VR1 family “prototype.”
Figure 2
Alignment of the amino acid and corresponding nucleotide sequence of each VR2 family “prototype.”
Similar articles
- Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature.
Sacchi CT, Lemos AP, Brandt ME, Whitney AM, Melles CE, Solari CA, Frasch CE, Mayer LW. Sacchi CT, et al. Clin Diagn Lab Immunol. 1998 Nov;5(6):845-55. doi: 10.1128/CDLI.5.6.845-855.1998. Clin Diagn Lab Immunol. 1998. PMID: 9801347 Free PMC article. - PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine.
Sorhouet Pereira C, Regueira M, Mollerach M. Sorhouet Pereira C, et al. J Med Microbiol. 2008 Mar;57(Pt 3):338-342. doi: 10.1099/jmm.0.47631-0. J Med Microbiol. 2008. PMID: 18287297 - Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread.
Jelfs J, Munro R, Wedege E, Caugant DA. Jelfs J, et al. Clin Diagn Lab Immunol. 2000 May;7(3):390-5. doi: 10.1128/CDLI.7.3.390-395.2000. Clin Diagn Lab Immunol. 2000. PMID: 10799451 Free PMC article. - Molecular typing of meningococci: recommendations for target choice and nomenclature.
Jolley KA, Brehony C, Maiden MC. Jolley KA, et al. FEMS Microbiol Rev. 2007 Jan;31(1):89-96. doi: 10.1111/j.1574-6976.2006.00057.x. Epub 2006 Dec 1. FEMS Microbiol Rev. 2007. PMID: 17168996 Review. - Genotypic characterization of Neisseria meningitidis using Pyrosequencing.
Diggle MA, Clarke SC. Diggle MA, et al. Mol Biotechnol. 2004 Oct;28(2):139-45. doi: 10.1385/mb:28:2:139. Mol Biotechnol. 2004. PMID: 15477653 Review.
Cited by
- Characterizing Neisseria meningitidis in Southern Vietnam between 2012 and 2021: A predominance of the chloramphenicol-resistant ST-1576 lineage.
Phan TV, Vo DTT, Nguyen HTK, Ho TNL, Pham QD, Luong QC, Cao TM, Nguyen TV, Taha MK, Nguyen TV. Phan TV, et al. IJID Reg. 2023 Nov 19;10:52-59. doi: 10.1016/j.ijregi.2023.11.013. eCollection 2024 Mar. IJID Reg. 2023. PMID: 38162295 Free PMC article. - Microevolution and Its Impact on Hypervirulence, Antimicrobial Resistance, and Vaccine Escape in Neisseria meningitidis.
Mikucki A, Kahler CM. Mikucki A, et al. Microorganisms. 2023 Dec 18;11(12):3005. doi: 10.3390/microorganisms11123005. Microorganisms. 2023. PMID: 38138149 Free PMC article. Review. - Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial.
Chang CM, Awanye AM, Marsay L, Dold C, Pollard AJ, Rollier CS, Feavers IM, Maiden MCJ, Derrick JP. Chang CM, et al. Vaccine. 2022 Jun 21;40(28):3835-3842. doi: 10.1016/j.vaccine.2022.05.032. Epub 2022 May 21. Vaccine. 2022. PMID: 35610106 Free PMC article. Clinical Trial. - Symptomatic Female Genital Tract Infections Due to Neisseria meningitidis in Athens, Greece.
Tsakalos A, Xirogianni A, Ekonomou G, Papandreou A, Prokopiou E, Vagiakou E, Tzanakaki G. Tsakalos A, et al. Diagnostics (Basel). 2021 Jul 14;11(7):1265. doi: 10.3390/diagnostics11071265. Diagnostics (Basel). 2021. PMID: 34359348 Free PMC article. - Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.
Marjuki H, Chang HY, Topaz N, Whaley MJ, Vuong J, Chen A, Jenkins LT, Hu F, Schmink S, Retchless AC, Thomas JD, Acosta AM, McNamara LA, Soeters HM, Mbaeyi S, Wang X. Marjuki H, et al. mBio. 2021 May 18;12(3):e00855-21. doi: 10.1128/mBio.00855-21. mBio. 2021. PMID: 34006659 Free PMC article.
References
- Pollard AJ, Maiden MCJ. Meningococcal disease. Totowa (NJ): Humana Press; 2001.
- Kuipers B, van den Dobbelsteen G, Wedege E, van Alphen L. Serological characterization. In: Pollard AJ, Maiden MC, editors. Meningococcal disease: methods and protocols. Totowa (NJ): Humana Press; 2001. p. 131–45. - PubMed
- Frasch CE, Zollinger WD, Poolman JT. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis. 1985;7:504–10. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources